Oct 31, 2018   SOURCE: PR NewsWire

Global Non-Hodgkin Lymphoma Therapeutics Market Outlook to 2025 featuring Novartis, Merck, GSK, Bayer, Pfizer, Celgene, and many more

DUBLIN, Oct. 31, 2018 /PRNewswire/ --

The "Global Non-Hodgkin Lymphoma Therapeutics Market Analysis 2018 - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The report contains up to date financial data derived from varied research sources to present unique

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

and reliable analysis.

Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report provides:

Key Topics Covered

    --  Market sizing estimations and forecasts across the given market segments
    --  Identifying market dynamics (Drivers, Restraints, Opportunities,
        Threats, Challenges)
    --  Strategic recommendations in key business segments based on the market
        estimations
    --  Regional and country level market analysis
    --  Competitive landscaping of major market players
    --  Company profiling covering the financials, recent activities and the
        future strategies


1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Non-Hodgkin Lymphoma Therapeutics Market by Therapeutics

    --  Chemotherapy
    --  Local Chemotherapy
    --  Systemic Chemotherapy
    --  Targeted Therapy
    --  Radiation Therapy
    --  Gamma-ray Therapy
    --  X-ray Therapy

6 Non-Hodgkin Lymphoma Therapeutics Market by Cancer Type

    --  Schwannomas
    --  Medulloblastoma
    --  Glioma
    --  Choroid Plexus Papilloma
    --  Oligodendroglioma
    --  Ependymoma
    --  Astrocytoma
    --  Meningioma
    --  Pituitary Adenoma

7 Non-Hodgkin Lymphoma Therapeutics Market by Type

    --  Stem Cell Transplant
    --  Immunotherapy
    --  Surgery and Radiation Therapy
    --  Chemotherapy
    --  Targeted Therapy
    --  Pharmacological
    --  Other Types

8 Non-Hodgkin Lymphoma Therapeutics Market by Cell Type

    --  T-Cell Lymphomas
    --  B-Cell Lymphomas
    --  AIDS-Related Lymphomas
    --  Mantel Cell Lymphoma
    --  Blastic NK-Cell Lymphoma
    --  Cutaneous T-Cell Lymphoma
    --  T-Cell Leukemia
    --  Burkitt's lymphoma
    --  Waldenstrom's Macroglobulinemia
    --  Follicular Lymphoma

9 Geographical Segmentation

10 Vendor Landscaping

11 Company Profiles

    --  Novartis
    --  Merck
    --  F. Hoffman La-Roche Ltd.
    --  GlaxoSmithKline (GSK) PLC
    --  Bristol Myers Squibb Co.
    --  Bayer AG
    --  Pfizer
    --  CTI Biopharma
    --  Kyowa Hakko Kirin
    --  Pharmacyclics/Janssen Biotech
    --  Millennium/Johnson-Johnson
    --  Celgene
    --  Spectrum Pharmaceuticals
    --  Seattle Genetics

For more information about this report visit https://www.researchandmarkets.com/research/2twnns/global?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-non-hodgkin-lymphoma-therapeutics-market-outlook-to-2025-featuring-novartis-merck-gsk-bayer-pfizer-celgene-and-many-more-300740563.html

SOURCE Research and Markets